Company intelligence / Profile preview

BreathTech

Austin, Texas, United States

Ownership: Private
Development stage: Other

Overview

BreathTech is developing the BreathTest-1000™, a rapid breath analyzer leveraging proprietary mass spectrometry technology for disease detection; clinical validation data are not yet available in the public domain, indicating the company is in pre-clinical or early-stage clinical development[1].

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on BreathTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BreathTech.

Explore the full profile